For example, the inhibition of the MEK/ERK pathway leads to activation of PI3K/mTOR signaling, but the combined targeting proved to reduce self-renewal and tumorigenic capacity of glioma stem cells [23]. The gene discussed is MAP2K7; the disease is central nervous system cancer.